[9] In other words, cagrilintide revived a decades-old hormonal axis in a once-weekly, combination-ready form
Their ability to dynamically regulate the folding, stabilization, and degradation of these proteins places them at the center of neuronal protein homeostasis
Most patients should be seen every four to eight weeks during dose escalation so side effects, weight loss, nutrition and medication adjustments can be monitored, Batsis says
Indeed, in models such as breast cancer, EPA/DHA treatment reduces the phosphorylation levels of kinases such as Akt and ERK, and inhibits the PI3K/Akt signaling pathway, which reduces pro-survival signaling and promotes apoptosis (50, 60)
Adding GIP receptor activation might further support these properties, suggesting that Tirzepatide might play a significant role in lipid regulation
Notably, we found that the frequency of administration emerged as a crucial factor influencing the observed effects, whereas the dose size showed secondary importance